Gilead Sciences, Inc. (GILD)
124.07
+2.31
(+1.90%)
USD |
NASDAQ |
Jan 14, 16:00
123.84
-0.23
(-0.19%)
After-Hours: 05:56
Gilead Sciences Market Cap: 153.93B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.14B |
| Johnson & Johnson | 526.55B |
| Eli Lilly & Co. | 960.61B |
| Merck & Co., Inc. | 275.53B |
| Regeneron Pharmaceuticals, Inc. | 79.26B |
Market Cap Related Metrics
| PE Ratio | 19.22 |
| PS Ratio | 5.367 |
| PEG Ratio | 0.0027 |
| Price to Book Value | 7.146 |
| Price to Free Cash Flow | 17.02 |
| Price | 124.07 |
| Earnings Yield | 5.20% |
| PEGY Ratio | 0.0027 |
| Operating PE Ratio | 13.75 |
| Normalized PE Ratio | 17.95 |